Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes

BACKGROUND: To assess the practice patterns of the recurrence score (RS) based on the 21-gene expression assay on adjuvant chemotherapy recommendations and survival outcomes in estrogen receptor-positive (ER+)/HER2- breast cancer (BC) with one to three positive lymph nodes (N1). METHODS: We included...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guan-Qiao, Xie, Shang-Jin, Wu, San-Gang, He, Zhen-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980792/
https://www.ncbi.nlm.nih.gov/pubmed/36875478
http://dx.doi.org/10.3389/fendo.2023.1103949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980792/
https://www.ncbi.nlm.nih.gov/pubmed/36875478
http://dx.doi.org/10.3389/fendo.2023.1103949

Ejemplares similares